🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objectives: Objectives The primary objective of this study is to: To ass...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2015-05-20
Trial ID
NCT02293005
Treatments Being Tested
This phase I/II trial studies the side effects and the best dose of MLN8237...
Status
Terminated
Location
Fox Chase Cancer Center
Start Date
2011-10-20
Trial ID
NCT01471964
Treatments Being Tested
This phase I trial studies the side effects and best dose of alisertib and ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2013-07-17
Trial ID
NCT01897012
Treatments Being Tested
This is a phase 3, randomized, 2-arm, open-label, international trial evalu...
Status
Completed
Location
Multiple Locations
Start Date
2012-06-11
Trial ID
NCT01482962
Treatments Being Tested
This phase I/Ib study is designed to establish the safety and maximum toler...
Status
Terminated
Location
City of Hope Comprehensive Cancer Center
Start Date
2016-10
Trial ID
NCT02700022
Treatments Being Tested
This is a multicenter, dose escalation, phase 1 study of MLN8237 in adult p...
Status
Completed
Location
Ciutat Sanitaria Vall d'Hebron - Servicio de Oncologia
Start Date
2007-10-22
Trial ID
NCT00651664
Treatments Being Tested
This study will assess the effect of multi-dose administration of itraconaz...
Status
Completed
Location
Multiple Locations
Start Date
2014-10-22
Trial ID
NCT02259010
Treatments Being Tested
This phase I trial studies the side effects and best dose of alisertib when...
Status
Completed
Location
Smilow Cancer Center/Yale-New Haven Hospital
Start Date
2015-08-27
Trial ID
NCT02319018
Treatments Being Tested
The goal of the first part of this clinical trial (Phase I portion) is to s...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2012-05
Trial ID
NCT01601535
Treatments Being Tested
This is a phase Ib study designed to evaluate the safety and toxicity of th...
Status
Completed
Location
University of Colorado Cancer Center
Start Date
2016-05-13
Trial ID
NCT02719691